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Purpose. Head and neck cancer treatment is associated with signiﬁcant morbidities. Both exclusive radiotherapy (RT) and
chemoradiotherapy (CHRT) treatments can produce, as side effects, increased rates of long-term dysphagia. The purpose of the
study here presented was to evaluate the ability of videoﬂuoroscopy (VDF) in detecting and measuring swallowing dysfunction
secondary to treatments.
Methods and materials. Eight head-and-neck cancer patients, who underwent radical RT till 70Gy (5 fractions per week, 2Gy per
fraction), and concurrent chemotherapy (CHT)when indicated, were included. Treatment schedules administered to each patient
(RT total dose, radiation ﬁelds, delivery techniques, CHT schemes) were decided according the NCCN recommendations. Half
of patients received exclusive RT and the other half concomitant CHRT. In order to evaluate a possible swallowing dysfunction,
VDF were performed before and after the treatment. Patients presenting swallowing dysfunction before the treatment were
excluded. Post-treatment evaluation was undertaken twice: early (1–3 months) and late post-therapy (4–9 months). The VDF
explored swallowing dysfunction with the standard different textures.
Results. 3 patients developed some swallowing dysfunction in early post-therapy evaluation and, in the late post-therapy evalua-
tion, 7 patients showed propulsive defect of the pharynx and 6 of them had also residue. Only one patient had symptoms related
to this dysfunction. No case of pneumonia by aspiration was reported.
Conclusions. Swallowing dysfunction is a prevalent side effect after intensive RT and CHRT treatment in head-and-neck cancer
patients. In our ﬁrst 8 patients included, most frequent swallowing dysfunction was the propulsive defect of the pharynx asymp-
tomatic in most of the cases. VDF was very effective in detecting, measuring and controlling this side effect. However, in order
to conﬁrm these results, inclusion of more patients is required. Therefore, patient enrolment continues.
http://dx.doi.org/10.1016/j.rpor.2013.03.290
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Introduction. Radiation therapy is an effective treatment in primary/recurrent head and neck cancer (HNC) arising in previously
irradiated volumes (PIVs) but severe late toxicities have been related.
Objective. To assess the efﬁcacy and toxicity of Helical Tomotherapy (HT) as re-irradiation treatment in primary/recurrent HNC
in PIVs.
Materials and methods. From August 2009 to February 2013, 20 HNC patients with prior-radiation have been re-treated with HT. A
median age of 62 years (range, 41–79 years). Sixty-ﬁve percent of tumors were recurrences emerging in PIVs: skull base (n=4),
pharynx (n=3), oral cavity (n=1), nasopharynx (n=1), nodal cervical area (n=1), facial area (n=2), tiroid area (n=1). Thirty-ﬁve
percent were second primary tumors in PIVs: nasopharynx (n=2), oropharynx (n=2), oral cavity (n=1), hypopharynx (n=1), and
nasal fossa (n=1). Six patients (30%) underwent surgical resection prior re-irradiation. Previous dosimetry (dose distriburion,
prescrioption dose and dose delivered to organs at risk) was taken into account in re-irradiation treatment planning. Concomi-
tant/neoadyuvant platinum-based chemotherapy was administrated in 55% of patients. Toxicities were documented according
to the RTOG scoring criteria.
Results. Median follow-up was 9 months (range, 1–37 months). The median radiation dose in patients with surgical resection
(n=6) was 63Gy (range, 48.6–70Gy), two patients received 70Gy for gross tumor in surgical margin. The patients with irresectable
tumor (n=14) received a median radical doses of 68.3Gy (range, 52–70.2Gy). The relevant toxicity RTOG ≥3 was: acute toxicity:
grade 3: 25% (radiodermatitis n=2, mucositis n=3); Grade 4–5: 0%; Late toxicity (evaluated in 16 patients due to the limited
time of follow-up) was: Grade 3: 13% (xerostomia: n=1, aplasia n=1); Grade 4–5: 0%. At time of analysis 2 local progressions, 3
locorregional and 7 distant failures have been observed.
Conclusions. According to our data, HT could be considered as a radiation option in patients previously irradiated as showed by
an acceptable proﬁle of toxicity.
http://dx.doi.org/10.1016/j.rpor.2013.03.291
Treatment with intensity modulated radiation therapy (IMRT) for nasopharyngeal carcinoma
M. Pagola Divassón, D. Ortiz de Urbina, E. Saenz de Urturi, J. Rosa Nieto
Instituto Oncológico, Oncología Radioterápica
Introduction. IMRT allows normal tissue preservation of uninvolved anatomical structures immediately adjacent to the tumor in
nasopharyngeal carcinoma (NPC) patients.
Objective. To determine the toxicity of IMRT in NPC patients treated with Helical Tomotherapy (HT) or Linac.
